植え込み型ドラッグデリバリーデバイス市場：製品、技術、用途別-2025-2030年の世界予測

植え込み型ドラッグデリバリーデバイス市場は、2023年に197億8,000万米ドルと評価され、2024年には215億3,000万米ドルに達すると予測され、CAGR 8.91％で成長し、2030年には359億7,000万米ドルに達すると予測されています。

植え込み型ドラッグデリバリーデバイス市場は、長時間にわたって正確で的を絞った薬物送達を可能にする臨床ソリューションに重点を置くことで定義されます。これらのデバイスは、薬物のバイオアベイラビリティと患者のコンプライアンスを向上させる能力があるため、特に糖尿病、がん、ホルモン障害などの慢性疾患には不可欠です。最終用途は疼痛管理からワクチン投与まで多岐にわたり、患者ケアの分散化が重視されるようになったため、病院、外来、在宅ヘルスケアなどが最終用途となっています。この市場の主な成長要因は、個別化医療を重視し、ナノテクノロジーやスマートポリマーのようなバイオテクノロジーの進歩により、より効果的で汎用性の高い埋め込み型ソリューションが可能になるという、進化する世界のヘルスケア情勢を中心に展開されています。慢性疾患の増加や世界人口の高齢化が需要をさらに高めています。最近の技術的チャンスは、薬物放出制御システムや生分解性インプラントの進歩です。新たな機会としては、精密医療に重点を置くバイオテクノロジー企業との提携や、デバイスの適合性と患者の転帰を改善するための材料科学における継続的な技術革新が挙げられます。しかし、研究開発の高コスト、厳しい規制経路、長期的な安全性の証明、手術合併症の脅威といった限界は、依然として大きな課題です。また、法的・倫理的な懸念も、特にデジタルモニタリング機能を備えた機器における患者のプライバシーに関するハードルとなっています。イノベーションを促進するために、企業はリアルタイムでの患者モニタリングのためのセンサーとAIの統合、ドラッグデリバリーの迅速な調整の確保、医療廃棄物に関連する環境問題に対処するための新しい生分解性材料の探求に注力することができます。研究開発投資の急増や、製品ポートフォリオの充実を目的とした戦略的合併によって特徴づけられるように、市場の性質は急速に適応しています。そのため、企業は分野横断的なイノベーションに投資し、AIとIoTを活用したパートナーシップを構築して競争優位性を確保し、進化する市場の需要への適応性を確保する必要があります。

市場力学：急速に進化する植え込み型ドラッグデリバリーデバイス市場の主要市場インサイトを公開

植え込み型ドラッグデリバリーデバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • がんや糖尿病などの慢性疾患の罹患率の増加
  • 投薬技術の進歩
  • 患者の安全性を監視し、頻繁な投与ミスを回避するための輸液ポンプの採用
• 市場抑制要因
  • 機器の高コスト
• 市場機会
  • 特殊輸液システムの採用拡大
  • 植え込み型ドラッグデリバリーデバイスの進歩に向けた合併活動の活発化
• 市場の課題
  • 医療ミスによる製品回収の顕著な発生

ポーターの5つの力：植え込み型ドラッグデリバリーデバイス市場をナビゲートする戦略ツール

ポーターの5つの力」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：植え込み型ドラッグデリバリーデバイス市場における外部からの影響の把握

外部マクロ環境要因は、植え込み型ドラッグデリバリーデバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析植え込み型ドラッグデリバリーデバイス市場における競合情勢の把握

植え込み型ドラッグデリバリーデバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス植え込み型ドラッグデリバリーデバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、植え込み型ドラッグデリバリーデバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨植え込み型ドラッグデリバリーデバイス市場における成功への道筋を描く

植え込み型ドラッグデリバリーデバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんや糖尿病などの慢性疾患の発症率の増加
    • 投薬技術の進歩
    • 患者の安全を監視し、頻繁な投薬ミスを回避するために輸液ポンプを導入する
  • 抑制要因
    • デバイスのコストが高い
  • 機会
    • 特殊輸液システムの採用増加
    • 植え込み型ドラッグデリバリーデバイスの発展に向けた合併活動の増加
  • 課題
    • 医療ミスによる製品回収の顕著な事例
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 植え込み型ドラッグデリバリーデバイス市場：製品別

• 生体吸収性ステント
• 近接放射線療法の種子
• 冠動脈薬剤溶出ステント
• 薬剤注入ポンプ
• 埋め込み型避妊器具
• 埋め込み型眼内デバイス

第7章 植え込み型ドラッグデリバリーデバイス市場：技術別

• 生分解性
• 生分解性なし
• スマートピル

第8章 植え込み型ドラッグデリバリーデバイス市場：用途別

• 心臓病学
• 避妊薬
• 腫瘍学
• 眼科

第9章 南北アメリカの植え込み型ドラッグデリバリーデバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の植え込み型ドラッグデリバリーデバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの植え込み型ドラッグデリバリーデバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• ALIMERA SCIENCES, INC.
• B. Braun SE
• Baxter International Inc.
• Bayer AG
• Boston Scientific Corporation
• Concept Medical
• Delpor Inc.
• ICU Medical, Inc.
• Koninklijke DSM N.V.
• Medtronic plc
• Merck KGaA
• P+F Products+Features GmbH
• Teleflex Incorporated
• Teva Pharmaceuticals Industries Ltd.

LIST OF FIGURES

• FIGURE 1. IMPLANTABLE DRUG DELIVERY DEVICE MARKET RESEARCH PROCESS
• FIGURE 2. IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. IMPLANTABLE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. IMPLANTABLE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. IMPLANTABLE DRUG DELIVERY DEVICE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. IMPLANTABLE DRUG DELIVERY DEVICE MARKET DYNAMICS
• TABLE 7. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-ABSORBABLE STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BRACHYTHERAPY SEEDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CORONARY DRUG-ELUTING STENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE CONTRACEPTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY IMPLANTABLE INTRAOCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY BIO-DEGRADABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY NON-BIODEGRADABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY SMART PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. CANADA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. CHINA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. INDIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. ITALY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. POLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. QATAR IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM IMPLANTABLE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. IMPLANTABLE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. IMPLANTABLE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

The Implantable Drug Delivery Device Market was valued at USD 19.78 billion in 2023, expected to reach USD 21.53 billion in 2024, and is projected to grow at a CAGR of 8.91%, to USD 35.97 billion by 2030.

The implantable drug delivery device market is defined by its focus on clinical solutions allowing precise, targeted medication delivery over extended periods. These devices are vital due to their ability to enhance drug bioavailability and patient compliance, particularly for chronic diseases like diabetes, cancer, and hormonal disorders. Their applications span from managing pain to administering vaccines, with end-use sectors including hospitals, outpatient services, and home healthcare settings due to increasing emphasis on decentralized patient care. Key growth factors for this market revolve around the evolving global healthcare landscape, which emphasizes personalized medicine and advances in biotechnology like nano-technology and smart polymers, enabling more effective and versatile implantable solutions. Rising incidences of chronic diseases and the aging global population further compound demand. Recent technological opportunities arise with advancements in controlled drug release systems and biodegradable implants. Emerging opportunities include partnerships with biotech firms focused on precision medicine and continuous innovation in material science to improve device compatibility and patient outcomes. However, limitations like the high cost of research and development, stringent regulatory pathways, proving long-term safety, and the threat of surgical complications remain significant challenges. Legal and ethical concerns also pose hurdles, particularly regarding patient privacy in devices with digital monitoring capabilities. For fostering innovation, companies could focus on integrating sensors and AI for real-time patient monitoring, ensuring responsive adjustments to drug delivery, or exploring new biodegradable materials to address environmental concerns associated with medical waste. The nature of the market is rapidly adapting, characterized by a surge in R&D investments and strategic mergers aimed at enhancing product portfolios. Companies should thus invest in cross-disciplinary innovation and forge partnerships that leverage AI and IoT to secure competitive advantages, ensuring adaptability to evolving market demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Implantable Drug Delivery Device Market

The Implantable Drug Delivery Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence of chronic conditions, such as cancer and diabetes
  • Advances in medication administration techniques
  • Adoption of infusion pumps to monitor patient safety and avoid frequent dosage errors
• Market Restraints
  • High cost of devices
• Market Opportunities
  • Growing adoption of specialty infusion systems
  • Rising amalgamation activities for advancement in implantable drug delivery device
• Market Challenges
  • Noticeable incidences of product recall due to medical error

Porter's Five Forces: A Strategic Tool for Navigating the Implantable Drug Delivery Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Implantable Drug Delivery Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Implantable Drug Delivery Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Implantable Drug Delivery Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Implantable Drug Delivery Device Market

A detailed market share analysis in the Implantable Drug Delivery Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Implantable Drug Delivery Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Implantable Drug Delivery Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Implantable Drug Delivery Device Market

A strategic analysis of the Implantable Drug Delivery Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Implantable Drug Delivery Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ALIMERA SCIENCES, INC., B. Braun SE, Baxter International Inc., Bayer AG, Boston Scientific Corporation, Concept Medical, Delpor Inc., ICU Medical, Inc., Koninklijke DSM N.V., Medtronic plc, Merck KGaA, P+F Products + Features GmbH, Teleflex Incorporated, and Teva Pharmaceuticals Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Implantable Drug Delivery Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Bio-absorbable Stent, Brachytherapy Seeds, Coronary Drug-Eluting Stent, Drug Infusion Pumps, Implantable Contraceptive Devices, and Implantable Intraocular Devices.
• Based on Technology, market is studied across Bio-Degradable, Non-Biodegradable, and Smart Pills.
• Based on Application, market is studied across Cardiology, Contraceptive, Oncology, and Ophthalmology.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of chronic conditions, such as cancer and diabetes
    • 5.1.1.2. Advances in medication administration techniques
    • 5.1.1.3. Adoption of infusion pumps to monitor patient safety and avoid frequent dosage errors
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing adoption of specialty infusion systems
    • 5.1.3.2. Rising amalgamation activities for advancement in implantable drug delivery device
  • 5.1.4. Challenges
    • 5.1.4.1. Noticeable incidences of product recall due to medical error
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Implantable Drug Delivery Device Market, by Product

• 6.1. Introduction
• 6.2. Bio-absorbable Stent
• 6.3. Brachytherapy Seeds
• 6.4. Coronary Drug-Eluting Stent
• 6.5. Drug Infusion Pumps
• 6.6. Implantable Contraceptive Devices
• 6.7. Implantable Intraocular Devices

7. Implantable Drug Delivery Device Market, by Technology

• 7.1. Introduction
• 7.2. Bio-Degradable
• 7.3. Non-Biodegradable
• 7.4. Smart Pills

8. Implantable Drug Delivery Device Market, by Application

• 8.1. Introduction
• 8.2. Cardiology
• 8.3. Contraceptive
• 8.4. Oncology
• 8.5. Ophthalmology

9. Americas Implantable Drug Delivery Device Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Implantable Drug Delivery Device Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Implantable Drug Delivery Device Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ALIMERA SCIENCES, INC.
• 3. B. Braun SE
• 4. Baxter International Inc.
• 5. Bayer AG
• 6. Boston Scientific Corporation
• 7. Concept Medical
• 8. Delpor Inc.
• 9. ICU Medical, Inc.
• 10. Koninklijke DSM N.V.
• 11. Medtronic plc
• 12. Merck KGaA
• 13. P+F Products + Features GmbH
• 14. Teleflex Incorporated
• 15. Teva Pharmaceuticals Industries Ltd.